The terms governing use of GLP-1 Price Guide.
Effective June 1, 2026
By accessing GLP-1 Price Guide (https://glponepriceguide.com), you accept these Terms of Use.
GLP-1 Price Guide is an editorial pricing publication. We do not provide medical advice, diagnosis, or treatment. Content is for educational purposes only. Always consult a licensed healthcare provider for medical decisions.
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Coverage on this site is educational and pricing-focused; it does not constitute endorsement.
Pricing data is verified monthly from publicly available sources. Pricing changes frequently. Always confirm current pricing directly with the provider before enrolling. We do not guarantee the accuracy of any pricing figure at any future point.
This site analyzes pricing transparency. It does not constitute medical, legal, or financial advice. Decisions about GLP-1 treatment should be made with a licensed clinician based on individual medical circumstances.
Content on this site is © 2026 GLP-1 Price Guide. Pricing data is sourced from public provider pages and properly attributed. You may quote short excerpts with attribution; you may not republish substantial content without permission.
We link to provider websites, FDA pages, and other resources for reader convenience. We are not responsible for content on linked sites. Links do not constitute endorsement.
The site is provided "as is" without warranties of any kind. We do not guarantee uptime, accuracy, or fitness for any purpose.
To the maximum extent permitted by law, GLP-1 Price Guide is not liable for any damages arising from use of this site or reliance on its content. Always verify pricing and medical information independently.
These Terms may be updated. Material changes will be noted at the top of this page.
For questions about these Terms, email glponepriceguide@gmail.com.